Literature DB >> 19709670

Effect of changes in left ventricular anatomy and conduction velocity on the QRS voltage and morphology in left ventricular hypertrophy: a model study.

Ljuba Bacharova1, Vavrinec Szathmary, Matej Kovalcik, Anton Mateasik.   

Abstract

UNLABELLED: The increased QRS voltage is considered to be a specific electrocardiogram (ECG) sign of left ventricular hypertrophy (LVH), and it is expected that the QRS voltage reflects the increase in left ventricular mass (LVM). However, the increased QRS voltage is only one of QRS patterns observed in patients with LVH. According to the solid angle theory, the resultant QRS voltage is influenced not only by spatial (anatomic) but also by nonspatial (electrophysiologic) determinants. In this study, we used a computer model to evaluate the effect of changes in anatomy and conduction velocity of the left ventricle on QRS complex characteristics.
MATERIAL AND METHODS: The model defines the geometry of cardiac ventricles analytically as parts of ellipsoids and allows to change dimensions of the ventricles, as well as the conduction velocity in the individual layers of myocardium. Three types of anatomic changes were simulated: concentric hypertrophy, eccentric hypertrophy, and dilatation. The conduction velocity was slowed in the inner layer of the left ventricle representing the Purkinje fiber mesh and in the layers representing the working myocardium. The outcomes of the model are presented as the time course of the spatial QRS vector magnitude, the vectorcardiographic QRS loops (VCGs) in horizontal, left sagittal, and frontal planes, as well as derived 12-lead ECGs. The following indicators of the 12-lead ECG were evaluated: the left axis deviation, the intrinsicoid deflection in V6, Cornell voltage, Cornell voltage-duration product, and Sokolow-Lyon index.
RESULTS: The increase in LVM did not affect the QRS voltage proportionally, and the LVM and type of hypertrophy were not the only determinants of the QRS patterns. The conduction velocity slowing resulted in a spectrum of QRS patterns including increased QRS voltage and duration, left axis deviation, prolonged intrinsicoid deflection, VCG patterns of left bundle branch block, as well as pseudo-normal VCG/ECG patterns. The anatomic changes and conduction velocity slowing affected differently Sokolow-Lyon index and Cornell criteria.
CONCLUSION: We showed that the LVM is not the only determinant of the QRS complex changes in LVH, but it is rather a combination of anatomic and electric remodeling that creates the whole spectrum of the QRS complex changes seen in LVH patients. The slowed conduction velocity in the model heart produced QRS patterns consistent with changes described in LVH, even if the LVM was not changed. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19709670     DOI: 10.1016/j.jelectrocard.2009.07.014

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  21 in total

Review 1.  Left ventricular hypertrophy: The relationship between the electrocardiogram and cardiovascular magnetic resonance imaging.

Authors:  Ljuba Bacharova; Martin Ugander
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

2.  Obesity and hypertension contribute to prolong QRS complex duration among middle-aged adults.

Authors:  Dillon J Dzikowicz; Mary G Carey
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-05-29       Impact factor: 1.468

3.  Electrocardiographic left ventricular hypertrophy predicts atrial fibrillation independent of left ventricular mass.

Authors:  Nikhil Patel; Wesley T O'Neal; S Patrick Whalen; Elsayed Z Soliman
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-12-25       Impact factor: 1.468

4.  Delayed intrinsicoid deflection of the QRS complex is associated with sudden cardiac arrest.

Authors:  Navid Darouian; Kumar Narayanan; Aapo L Aro; Kyndaron Reinier; Audrey Uy-Evanado; Carmen Teodorescu; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  Heart Rhythm       Date:  2015-12-14       Impact factor: 6.343

5.  Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly.

Authors:  Wesley T O'Neal; Mohamed F Almahmoud; Waqas T Qureshi; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2015-07-04       Impact factor: 2.136

6.  Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.

Authors:  J Adam Leigh; Wesley T O'Neal; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2016-03-19       Impact factor: 2.778

7.  Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging.

Authors:  Ljuba Bacharova; Haiying Chen; E Harvey Estes; Anton Mateasik; David A Bluemke; Joao A C Lima; Gregory L Burke; Elsayed Z Soliman
Journal:  Am J Cardiol       Date:  2014-11-29       Impact factor: 2.778

8.  Electrocardiogram Derived QRS Duration >120 ms is Associated With Elevated Plasma Homocysteine Levels in a Rural Australian Cross-Sectional Population.

Authors:  Yvonne Lee Yin Leng; Yuling Zhou; Honghong Ke; Herbert Jelinek; Joel McCabe; Hassan Assareh; Craig S McLachlan
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

9.  Cardiac Amyloidosis with Discordant QRS Voltage between Frontal and Precordial Leads.

Authors:  Csilla-Andrea Eötvös; Roxana-Daiana Lazar; Iulia-Georgiana Zehan; Erna-Brigitta Lévay-Hail; Giorgia Pastiu; Mihaela Pop; Anca Simona Bojan; Sorin Pop; Dan Blendea
Journal:  Medicina (Kaunas)       Date:  2021-06-27       Impact factor: 2.430

10.  ECG marker of adverse electrical remodeling post-myocardial infarction predicts outcomes in MADIT II study.

Authors:  Larisa G Tereshchenko; Scott McNitt; Lichy Han; Ronald D Berger; Wojciech Zareba
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.